The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

Updated daily with latest market intelligence

Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation

Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.

Twist Bioscience secures $120M Series D for biotech innovation

Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.

Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation

Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.

BioSynth Labs raises $380M Series B in September 2025 funding round

BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.

BioSynthetic Materials

BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology

BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.

NeuroPharma raises $190M Series B in September 2025 funding round

NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.

Anthropic raises $4B from Amazon in landmark AI safety deal

Amazon invests up to $4 billion in Anthropic, the AI safety startup behind Claude, marking one of the largest AI investments to date and reshaping the competitive landscape.